Subsequently, the resulting phenotype of this UGT2B15 polymorphism is a quicker androgen metabolite clearance which may raise the “effective” amount of steroids within the prostate and decrease risk for prostate cancer [21]. This evidence concerns the gene UGT2B15 and Familial prostate cancer.